Cogent Biosciences Inc (COGT)
8.91
-0.74
(-7.67%)
USD |
NASDAQ |
Nov 15, 16:00
9.27
+0.36
(+4.04%)
After-Hours: 18:22
Cogent Biosciences Total Liabilities (Quarterly): 56.71M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 56.71M |
| March 31, 2024 | 53.78M |
| December 31, 2023 | 55.64M |
| September 30, 2023 | 52.55M |
| June 30, 2023 | 43.94M |
| March 31, 2023 | 39.64M |
| December 31, 2022 | 45.08M |
| September 30, 2022 | 41.62M |
| June 30, 2022 | 46.67M |
| March 31, 2022 | 19.01M |
| December 31, 2021 | 17.91M |
| September 30, 2021 | 18.15M |
| June 30, 2021 | 15.71M |
| Date | Value |
|---|---|
| March 31, 2021 | 10.85M |
| December 31, 2020 | 16.25M |
| September 30, 2020 | 23.81M |
| June 30, 2020 | 11.81M |
| March 31, 2020 | 13.24M |
| December 31, 2019 | 17.66M |
| September 30, 2019 | 29.26M |
| June 30, 2019 | 29.55M |
| December 31, 2018 | 25.69M |
| September 30, 2018 | 27.26M |
| June 30, 2018 | 26.05M |
| March 31, 2018 | 27.52M |
| December 31, 2017 | 20.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.85M
Minimum
Mar 2021
56.71M
Maximum
Jun 2024
31.58M
Average
23.81M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 429.94M |
| Shareholders Equity (Quarterly) | 373.22M |